BENITEC BIOPHARMA LTD's ticker is BNTC and the CUSIP is 082053307. A total of 4 filers reported holding BENITEC BIOPHARMA LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $971,000 | +149.6% | 1,365,615 | +436.7% | 0.52% | +2173.9% |
| Q4 2016 | $389,000 | -11.2% | 254,445 | -26.4% | 0.02% | 0.0% |
| Q2 2016 | $438,000 | -40.7% | 345,576 | -18.1% | 0.02% | -37.8% |
| Q1 2016 | $739,000 | -68.9% | 422,101 | -29.3% | 0.04% | -71.8% |
| Q4 2015 | $2,377,000 | -23.5% | 597,115 | +18.2% | 0.13% | +2.3% |
| Q3 2015 | $3,107,000 | – | 505,220 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,365,615 | $971,000 | 0.52% |
| Virtu Financial LLC | 11,263 | $8,000 | 0.00% |
| UBS Group AG | 6,009 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 79,200 | $56,000 | 0.00% |
| Renaissance Technologies | 13,700 | $10,000 | 0.00% |